No Data
No Data
10-Q: Quarterly report
StockNews.com Initiates Coverage on Zevra Therapeutics (NASDAQ:KMPH)
Equities research analysts at StockNews.com began coverage on shares of Zevra Therapeutics (NASDAQ:KMPH – Get Rating) in a research report issued on Sunday. The firm set a "hold" rating on the special
Zevra Therapeutics (NASDAQ:KMPH) Coverage Initiated by Analysts at StockNews.com
StockNews.com began coverage on shares of Zevra Therapeutics (NASDAQ:KMPH – Get Rating) in a report published on Friday morning. The brokerage issued a hold rating on the specialty pharmaceutical comp
Zevra Therapeutics (NASDAQ:KMPH) Receives New Coverage From Analysts at StockNews.com
Equities research analysts at StockNews.com assumed coverage on shares of Zevra Therapeutics (NASDAQ:KMPH – Get Rating) in a research report issued to clients and investors on Thursday. The firm set a
Zevra Therapeutics, Inc. (NASDAQ:KMPH) Short Interest Down 5.5% in February
Zevra Therapeutics, Inc. (NASDAQ:KMPH – Get Rating) was the recipient of a large decline in short interest in February. As of February 15th, there was short interest totalling 1,370,000 shares, a dec
Zevra Therapeutics (KMPH) Set to Announce Quarterly Earnings on Tuesday
Zevra Therapeutics (NASDAQ:KMPH – Get Rating) is scheduled to issue its quarterly earnings data before the market opens on Tuesday, March 7th. Analysts expect the company to announce earnings of ($0.
No Data